首页 > 最新文献

Endocrine regulations最新文献

英文 中文
The relationship between breast cancer and thyroid autoimmune disorders in southeast Iran: A case-control study. 伊朗东南部乳腺癌与甲状腺自身免疫性疾病的关系:一项病例对照研究
Q3 Medicine Pub Date : 2024-12-09 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0030
Shahin Nosratzehi, Seyed Mehdi Hashemi, Abolfazl Payandeh, Ahmad Bolouri, Fahimeh Okati

Objective. To better understand the role of thyroid hormones in regulating the growth of breast epithelial cells and the estrogen-like effects of these hormones, the present study was conducted to investigate the relationship between breast cancer and thyroid autoimmune disorders in southeast Iran women. Methods. In this case-control study, in the case group, all newly diagnosed breast cancer pa-tients referred to the oncology clinics in Zahedan city in years 2021‒2022 were studied. The num-ber of participants in each group was represented by 40 breast cancer patients. The control group was represented by women without breast cancer. The sampling method was simple or available using the nonprobability method. The presence or absence of thyroid dysfunction was checked using thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine (FT3), anti-thyroid peroxidase (TPO), and anti-thyroglobulin (Tg) tests. Results. The mean age of participants was 47±11 years. The risk of subclinical hyperthyroid-ism was higher in subjects with breast cancer and about 8 times higher than in the healthy ones (OR=8.27). According to the value of OR=1, the risk of developing autoimmune thyroid disease was the same in individuals with breast cancer as in healthy individuals. The odds ratio of hypothy-roidism could not be calculated because the value in the control group was zero. Conclusion. The results of this study show that there are abnormal characteristics of the thy-roid gland in breast cancer patients compared to the control group. The incidence of subclinical hyperthyroidism was significantly increased in the breast cancer patients. However, there was no difference in the incidence of autoimmune thyroid disease between the two groups.

目标。为了更好地了解甲状腺激素在调节乳腺上皮细胞生长中的作用以及这些激素的雌激素样作用,本研究调查了伊朗东南部妇女乳腺癌与甲状腺自身免疫性疾病之间的关系。方法。在本病例对照研究中,病例组研究了2021-2022年在扎黑丹市肿瘤诊所转诊的所有新诊断的乳腺癌患者。每组的参与者人数由40名乳腺癌患者代表。对照组以未患乳腺癌的女性为代表。抽样方法简单,或采用非概率方法。采用促甲状腺激素(TSH)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)、抗甲状腺过氧化物酶(TPO)和抗甲状腺球蛋白(Tg)试验检查是否存在甲状腺功能障碍。结果。参与者的平均年龄为47±11岁。乳腺癌患者发生亚临床甲状腺功能亢进的风险较高,约为健康人群的8倍(OR=8.27)。根据OR=1的值,乳腺癌患者发生自身免疫性甲状腺疾病的风险与健康个体相同。由于对照组的比值比为零,因此无法计算性假性症的比值比。结论。本研究结果表明,与对照组相比,乳腺癌患者的甲状腺存在异常特征。乳腺癌患者亚临床甲状腺功能亢进的发生率明显增高。然而,两组之间自身免疫性甲状腺疾病的发生率没有差异。
{"title":"The relationship between breast cancer and thyroid autoimmune disorders in southeast Iran: A case-control study.","authors":"Shahin Nosratzehi, Seyed Mehdi Hashemi, Abolfazl Payandeh, Ahmad Bolouri, Fahimeh Okati","doi":"10.2478/enr-2024-0030","DOIUrl":"https://doi.org/10.2478/enr-2024-0030","url":null,"abstract":"<p><p><b>Objective.</b> To better understand the role of thyroid hormones in regulating the growth of breast epithelial cells and the estrogen-like effects of these hormones, the present study was conducted to investigate the relationship between breast cancer and thyroid autoimmune disorders in southeast Iran women. <b>Methods.</b> In this case-control study, in the case group, all newly diagnosed breast cancer pa-tients referred to the oncology clinics in Zahedan city in years 2021‒2022 were studied. The num-ber of participants in each group was represented by 40 breast cancer patients. The control group was represented by women without breast cancer. The sampling method was simple or available using the nonprobability method. The presence or absence of thyroid dysfunction was checked using thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine (FT3), anti-thyroid peroxidase (TPO), and anti-thyroglobulin (Tg) tests. <b>Results.</b> The mean age of participants was 47±11 years. The risk of subclinical hyperthyroid-ism was higher in subjects with breast cancer and about 8 times higher than in the healthy ones (OR=8.27). According to the value of OR=1, the risk of developing autoimmune thyroid disease was the same in individuals with breast cancer as in healthy individuals. The odds ratio of hypothy-roidism could not be calculated because the value in the control group was zero. <b>Conclusion.</b> The results of this study show that there are abnormal characteristics of the thy-roid gland in breast cancer patients compared to the control group. The incidence of subclinical hyperthyroidism was significantly increased in the breast cancer patients. However, there was no difference in the incidence of autoimmune thyroid disease between the two groups.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between serum thyroid hormone levels and symptoms severity in young children with autism. 自闭症幼儿血清甲状腺激素水平与症状严重程度之间的关系。
Q3 Medicine Pub Date : 2024-12-09 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0031
Maria Kopcikova, Barbara Raskova, Ivan Belica, Jan Bakos, Hana Celusakova, Zuzana Chladna, Jana Zibolenova, Daniela Ostatnikova

Objective. Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by impaired social interaction and communication, restrictive and repetitive patterns of behavior, interests and activities. The aim of this study was to determine the postnatal levels of thyroid hor-mones and investigate their association with the severity of ASD symptoms. Methods. The study included 56 children (46 boys and 10 girls) with ASD aged 24-42 months. For ASD diagnostics the Autism Diagnostic Observation Schedule - second version (ADOS-2) and the Autism Diagnostic Interview-Revised (ADI-R) - interview with the child's parents or guard-ians were used. Venous blood was drawn right after the diagnostic procedures to analyze serum thyroid-stimulating hormone (s-TSH), free triiodothyronine (s-fT3), and free thyroxine (s-fT4) levels. Linear regression analysis was conducted to assess the relationship between the concentra-tions of thyroid hormones and ASD symptoms severity. Results. Serum concentrations of measured hormones were within normal reference ranges in almost all children. Decline of s-TSH was significantly associated with an increase in the severity of impaired social interaction and impaired communication as rated by parents (ADI-R) and with a higher prevalence of stereotyped behavior as observed in the diagnostic examination (ADOS-2). A decrease in s-fT3 was associated with higher frequency of stereotyped behavior as assessed by parents (ADI-R). Neither sex nor age were significant predictors. Conclusion. Although thyroid hormone levels were normal, we demonstrated an association of thyroid hormones with ASD symptoms.

目标。自闭症谱系障碍(ASD)是一种神经发育障碍,其特征是社交互动和沟通受损,行为、兴趣和活动的限制性和重复性模式。本研究的目的是确定产后甲状腺激素水平,并调查其与ASD症状严重程度的关系。方法。该研究包括56名年龄在24-42个月的自闭症儿童(46名男孩和10名女孩)。对于ASD的诊断,使用自闭症诊断观察表-第二版(ADOS-2)和自闭症诊断访谈-修订版(ADI-R) -与儿童父母或监护人的访谈。诊断后立即抽取静脉血,分析血清促甲状腺激素(s-TSH)、游离三碘甲状腺原氨酸(s-fT3)和游离甲状腺素(s-fT4)水平。采用线性回归分析评估甲状腺激素浓度与ASD症状严重程度的关系。结果。几乎所有儿童的血清激素浓度均在正常参考范围内。s-TSH的下降与父母评定的社交障碍和沟通障碍严重程度的增加(ADI-R)以及诊断检查(ADOS-2)中观察到的刻板行为的更高患病率显著相关。经家长评估(ADI-R), s-fT3的减少与刻板行为的高频率相关。性别和年龄都不是显著的预测因素。结论。虽然甲状腺激素水平正常,但我们证明了甲状腺激素与ASD症状的关联。
{"title":"The relationship between serum thyroid hormone levels and symptoms severity in young children with autism.","authors":"Maria Kopcikova, Barbara Raskova, Ivan Belica, Jan Bakos, Hana Celusakova, Zuzana Chladna, Jana Zibolenova, Daniela Ostatnikova","doi":"10.2478/enr-2024-0031","DOIUrl":"https://doi.org/10.2478/enr-2024-0031","url":null,"abstract":"<p><p><b>Objective.</b> Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by impaired social interaction and communication, restrictive and repetitive patterns of behavior, interests and activities. The aim of this study was to determine the postnatal levels of thyroid hor-mones and investigate their association with the severity of ASD symptoms. <b>Methods.</b> The study included 56 children (46 boys and 10 girls) with ASD aged 24-42 months. For ASD diagnostics the Autism Diagnostic Observation Schedule - second version (ADOS-2) and the Autism Diagnostic Interview-Revised (ADI-R) - interview with the child's parents or guard-ians were used. Venous blood was drawn right after the diagnostic procedures to analyze serum thyroid-stimulating hormone (s-TSH), free triiodothyronine (s-fT3), and free thyroxine (s-fT4) levels. Linear regression analysis was conducted to assess the relationship between the concentra-tions of thyroid hormones and ASD symptoms severity. <b>Results.</b> Serum concentrations of measured hormones were within normal reference ranges in almost all children. Decline of s-TSH was significantly associated with an increase in the severity of impaired social interaction and impaired communication as rated by parents (ADI-R) and with a higher prevalence of stereotyped behavior as observed in the diagnostic examination (ADOS-2). A decrease in s-fT3 was associated with higher frequency of stereotyped behavior as assessed by parents (ADI-R). Neither sex nor age were significant predictors. <b>Conclusion.</b> Although thyroid hormone levels were normal, we demonstrated an association of thyroid hormones with ASD symptoms.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The expression of DNAJB9 in normal human astrocytes is more sensitive to nanographene oxide than in glioblastoma cells. 与胶质母细胞瘤细胞相比,正常人星形胶质细胞中 DNAJB9 的表达对纳米氧化物更敏感。
Q3 Medicine Pub Date : 2024-12-09 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0029
Oleksandr Minchenko, Yuliia V Kulish, Yuliia M Viletska, Olena O Khita, Olha V Rudnytska, Halyna E Kozynkevych, Dmytro O Minchenko

Objective. Nanographene oxide (nGO) nanoparticles (NPs) have unique properties and are widely used in various fields, including biomedicine. These NPs, however, also exhibit toxic ef-fects and therefore, the understanding of the molecular mechanism of nGO toxicity is very im-portant mainly for the nanomedicine, especially the cancer therapy. This study aimed to examine the impact of nGO NPs on the expression of genes associated with endoplasmic reticulum (ER) stress, proliferation, and cancerogenesis in both normal human astrocytes and U87MG glioblas-toma cells. Methods. Normal human astrocytes line NHA/TS and U87MG glioblastoma cells stable trans-fected by empty vector or dnERN1 (dominant-negative construct of ERN1) were exposed to low doses of nGO (1 and 4 ng/ml) for 24 h. RNA was extracted from the cells and used for cDNA syn-thesis. The expression levels of DNAJB9, EDEM1, DDIT3, ATF3, ATF4, TOB1, and IDH2 mRNAs were measured by quantitative polymerase chain reaction and normalized to ACTB mRNA. Results. We showed that treatment of normal astrocytes and glioblastoma cells by relatively small doses of nGO (1 and 4 ng/ml for 24 h) affected the expression level of DNAJB9, EDEM1, DDIT3, ATF3, ATF4, TOB1, and IDH2 mRNAs, but the sensitivity of all studied mRNA expres-sions to these NPs was significantly higher in normal astrocytes than in glioblastoma cells. The impact of nGO on these gene expressions is mediated by ER stress because ERN1 knockdown sup-presses the effect of these nanoparticles in glioblastoma cells. Conclusion. The data obtained demonstrate that the low doses of nGO disturbed the functional integrity of the genome preferentially through ER stress signaling and exhibit a more pronounced genotoxic effect in the normal astrocytes than the glioblastoma cells.

目标。纳米氧化石墨烯(nGO)纳米颗粒具有独特的性能,被广泛应用于包括生物医学在内的各个领域。然而,这些NPs也表现出毒性作用,因此,了解nGO毒性的分子机制主要对纳米医学,特别是癌症治疗非常重要。本研究旨在研究nGO NPs对正常人类星形胶质细胞和U87MG胶质母细胞瘤细胞内质网应激、增殖和癌变相关基因表达的影响。方法。将正常人星形胶质细胞系NHA/TS和U87MG胶质母细胞瘤细胞稳定转染空载体或dnERN1 (ERN1的显性阴性构建体),暴露于低剂量的nGO(1和4 ng/ml)中24小时,提取细胞RNA用于cDNA合成。定量聚合酶链反应检测DNAJB9、EDEM1、DDIT3、ATF3、ATF4、TOB1、IDH2 mRNA的表达水平,归一化为ACTB mRNA。结果。我们发现,用相对小剂量的nGO(1和4 ng/ml)处理正常星形胶质细胞和胶质母细胞瘤细胞24小时,会影响DNAJB9、EDEM1、DDIT3、ATF3、ATF4、TOB1和IDH2 mRNA的表达水平,但所有研究的mRNA表达对这些NPs的敏感性在正常星形胶质细胞中明显高于胶质母细胞瘤细胞。nGO对这些基因表达的影响是由内质网应激介导的,因为ERN1敲低抑制了这些纳米颗粒在胶质母细胞瘤细胞中的作用。结论。获得的数据表明,低剂量的nGO通过内质网应激信号优先干扰基因组的功能完整性,并且在正常星形胶质细胞中表现出比胶质母细胞瘤细胞更明显的遗传毒性作用。
{"title":"The expression of DNAJB9 in normal human astrocytes is more sensitive to nanographene oxide than in glioblastoma cells.","authors":"Oleksandr Minchenko, Yuliia V Kulish, Yuliia M Viletska, Olena O Khita, Olha V Rudnytska, Halyna E Kozynkevych, Dmytro O Minchenko","doi":"10.2478/enr-2024-0029","DOIUrl":"https://doi.org/10.2478/enr-2024-0029","url":null,"abstract":"<p><p><b>Objective.</b> Nanographene oxide (nGO) nanoparticles (NPs) have unique properties and are widely used in various fields, including biomedicine. These NPs, however, also exhibit toxic ef-fects and therefore, the understanding of the molecular mechanism of nGO toxicity is very im-portant mainly for the nanomedicine, especially the cancer therapy. This study aimed to examine the impact of nGO NPs on the expression of genes associated with endoplasmic reticulum (ER) stress, proliferation, and cancerogenesis in both normal human astrocytes and U87MG glioblas-toma cells. <b>Methods.</b> Normal human astrocytes line NHA/TS and U87MG glioblastoma cells stable trans-fected by empty vector or dnERN1 (dominant-negative construct of ERN1) were exposed to low doses of nGO (1 and 4 ng/ml) for 24 h. RNA was extracted from the cells and used for cDNA syn-thesis. The expression levels of DNAJB9, EDEM1, DDIT3, ATF3, ATF4, TOB1, and IDH2 mRNAs were measured by quantitative polymerase chain reaction and normalized to ACTB mRNA. <b>Results.</b> We showed that treatment of normal astrocytes and glioblastoma cells by relatively small doses of nGO (1 and 4 ng/ml for 24 h) affected the expression level of DNAJB9, EDEM1, DDIT3, ATF3, ATF4, TOB1, and IDH2 mRNAs, but the sensitivity of all studied mRNA expres-sions to these NPs was significantly higher in normal astrocytes than in glioblastoma cells. The impact of nGO on these gene expressions is mediated by ER stress because ERN1 knockdown sup-presses the effect of these nanoparticles in glioblastoma cells. <b>Conclusion.</b> The data obtained demonstrate that the low doses of nGO disturbed the functional integrity of the genome preferentially through ER stress signaling and exhibit a more pronounced genotoxic effect in the normal astrocytes than the glioblastoma cells.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hormonal biomarkers and preterm birth: insights from a study of pregnant women in Lahore, Pakistan. 荷尔蒙生物标志物与早产:巴基斯坦拉合尔孕妇研究的启示。
Q3 Medicine Pub Date : 2024-11-21 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0027
Sundas Akram, Shaaf Ahmad, Kaleem Maqsood, Javeria Malik, Muhammad Amir Iqbal, Husna Ahmad, Nabila Roohi

Objective. Reduced calciferol (vitamin D) levels in pregnant women have been associated with an increased risk to infant health. Progesterone sustains pregnancy and reduces the risk of premature birth through its metabolites affecting myometrial contractility. Sex hormone-binding globulin protein (SHBG) is a biomarker of premature birth. The present study aimed to find out if early pregnancy levels of vitamin D, SHBG, and progesterone metabolites may predict preterm birth risk. Methods. Five hundred pregnant women aged 18-43 years during their 2nd and 3rd trimesters from multiple civilian regional medical centers in Lahore participated in the study. Blood samples taken from participants were used to determine vitamin D, SHBG, 11-deoxycorticosterone (DOC), and 16α-hydroxyprogesterone (16α-OHP) levels using specific ELISA kits. Statistical analysis was performed by one-way ANOVA using the latest GraphPad Prism software. Results. A significant decrease in vitamin D, DOC, and SHBG levels (p<0.001, p<0.001, and p<0.05, respectively) in the preterm birth cohorts in the 2nd and 3rd trimester was found compared to the corresponding control groups. Furthermore, 16α-OHP levels in the preterm birth cohorts in the 2nd and 3rd trimesters were significantly increased (p<0.001 and p=0.0062, respectively) compared to their control cohorts. Conclusion. The results of our study confirm that calciferol deficiency in pregnant women is associated with an increased risk of premature birth and indicate that SHBG and progesterone metabolites may be useful biomarkers for the early identification and prediction of preterm birth.

目的。孕妇体内钙化醇(维生素 D)水平降低与婴儿健康风险增加有关。孕酮可维持妊娠,并通过其代谢产物影响子宫肌收缩力来降低早产风险。性激素结合球蛋白(SHBG)是早产的生物标志物。本研究旨在了解孕早期维生素 D、SHBG 和孕酮代谢物的水平是否可预测早产风险。研究方法来自拉合尔多个民用地区医疗中心的 500 名 18-43 岁的孕妇在怀孕的第二和第三季度参与了这项研究。使用特定的酶联免疫吸附试剂盒检测参与者的血样中维生素 D、SHBG、11-脱氧皮质酮(DOC)和 16α-羟孕酮(16α-OHP)的水平。统计分析采用最新的 GraphPad Prism 软件进行单因素方差分析。结果维生素 D、DOC 和 SHBG 水平明显降低(p 结论:我们的研究结果证实,钙化是导致男性不育的主要原因。我们的研究结果证实,孕妇缺乏钙化醇与早产风险增加有关,并表明 SHBG 和孕酮代谢物可能是早期识别和预测早产的有用生物标志物。
{"title":"Hormonal biomarkers and preterm birth: insights from a study of pregnant women in Lahore, Pakistan.","authors":"Sundas Akram, Shaaf Ahmad, Kaleem Maqsood, Javeria Malik, Muhammad Amir Iqbal, Husna Ahmad, Nabila Roohi","doi":"10.2478/enr-2024-0027","DOIUrl":"https://doi.org/10.2478/enr-2024-0027","url":null,"abstract":"<p><p><b>Objective.</b> Reduced calciferol (vitamin D) levels in pregnant women have been associated with an increased risk to infant health. Progesterone sustains pregnancy and reduces the risk of premature birth through its metabolites affecting myometrial contractility. Sex hormone-binding globulin protein (SHBG) is a biomarker of premature birth. The present study aimed to find out if early pregnancy levels of vitamin D, SHBG, and progesterone metabolites may predict preterm birth risk. <b>Methods.</b> Five hundred pregnant women aged 18-43 years during their 2nd and 3rd trimesters from multiple civilian regional medical centers in Lahore participated in the study. Blood samples taken from participants were used to determine vitamin D, SHBG, 11-deoxycorticosterone (DOC), and 16α-hydroxyprogesterone (16α-OHP) levels using specific ELISA kits. Statistical analysis was performed by one-way ANOVA using the latest GraphPad Prism software. <b>Results.</b> A significant decrease in vitamin D, DOC, and SHBG levels (p<0.001, p<0.001, and p<0.05, respectively) in the preterm birth cohorts in the 2nd and 3rd trimester was found compared to the corresponding control groups. Furthermore, 16α-OHP levels in the preterm birth cohorts in the 2nd and 3rd trimesters were significantly increased (p<0.001 and p=0.0062, respectively) compared to their control cohorts. <b>Conclusion.</b> The results of our study confirm that calciferol deficiency in pregnant women is associated with an increased risk of premature birth and indicate that SHBG and progesterone metabolites may be useful biomarkers for the early identification and prediction of preterm birth.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"225-232"},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual case of severe hyperbilirubinemia and thyrotoxicosis. 一个严重高胆红素血症和甲状腺毒症的不寻常病例。
Q3 Medicine Pub Date : 2024-11-21 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0025
Mohak Jain, Minal Shastri, Nilay Patel, Riya Dobariya, Abulkalam Sirajwala

Objective. We report a case of a 23-year-old pregnant female with five months of amenorrhea. She was referred to us with rapidly developing jaundice, anemia, and dyspnea with hyperthyroidism. Methods. After initial treatment of all the possible causes of progressive jaundice led to no improvement. The treatment was then heavily directed towards managing thyroid storm. Results. Hepatic dysfunction improved with iodine and thionamides. Patient recovered well. This points towards the uncommon association of severe hyperbilirubinemia with thyroid storm a potentially fatal endocrine disorder and its rapid improvement with iodine and thionamides. Conclusions. Our case suggests that severe hyperbilirubinemia can be caused by hyperthyroidism and the etiology of hepatic dysfunction should include thyrotoxicosis as a probable cause. Aggressive treatment should be done with iodine and thionamides for fruition.

目的。我们报告了一例闭经五个月的 23 岁孕妇。她因迅速出现黄疸、贫血和呼吸困难并伴有甲状腺功能亢进症而转诊至我院。治疗方法在对所有可能导致渐进性黄疸的原因进行初步治疗后,情况没有改善。于是,治疗重点转向控制甲状腺风暴。结果。使用碘和硫酰胺类药物后,肝功能异常得到改善。患者恢复良好。这说明严重高胆红素血症与甲状腺风暴这种可能致命的内分泌疾病相关的情况并不常见,而碘和硫酰胺类药物能迅速改善这种情况。结论我们的病例表明,严重的高胆红素血症可由甲状腺功能亢进引起,肝功能异常的病因应包括甲状腺毒症。应使用碘和硫代氨酰胺进行积极治疗,以取得疗效。
{"title":"An unusual case of severe hyperbilirubinemia and thyrotoxicosis.","authors":"Mohak Jain, Minal Shastri, Nilay Patel, Riya Dobariya, Abulkalam Sirajwala","doi":"10.2478/enr-2024-0025","DOIUrl":"10.2478/enr-2024-0025","url":null,"abstract":"<p><p><b>Objective.</b> We report a case of a 23-year-old pregnant female with five months of amenorrhea. She was referred to us with rapidly developing jaundice, anemia, and dyspnea with hyperthyroidism. <b>Methods.</b> After initial treatment of all the possible causes of progressive jaundice led to no improvement. The treatment was then heavily directed towards managing thyroid storm. <b>Results.</b> Hepatic dysfunction improved with iodine and thionamides. Patient recovered well. This points towards the uncommon association of severe hyperbilirubinemia with thyroid storm a potentially fatal endocrine disorder and its rapid improvement with iodine and thionamides. <b>Conclusions.</b> Our case suggests that severe hyperbilirubinemia can be caused by hyperthyroidism and the etiology of hepatic dysfunction should include thyrotoxicosis as a probable cause. Aggressive treatment should be done with iodine and thionamides for fruition.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"215-219"},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Various apolipoprotein E genotypes relate to responsiveness to flaxseed lignan complex in older persons with type 2 diabetes mellitus. 各种载脂蛋白 E 基因型与 2 型糖尿病老年人对亚麻籽木酚素复合物的反应有关。
Q3 Medicine Pub Date : 2024-11-21 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0026
Douglas E Barre, Kazimiera A Mizier-Barre, Odette Griscti

Objective. The objective of the study was to determine if there would be statistically significant differences or trends among apolipoprotein E genotypes in the responsiveness of members of a cluster of seven measures in older persons with type 2 diabetes mellitus (T2DM) consuming flaxseed lignan complex (FLC). The cluster of seven are abdominal obesity, hypertension, platelet hyperaggregability, hyperglycemia, dyslipidemia (decreased plasma levels of high-density lipoprotein cholesterol (HDLc), and increased plasma levels of triglycerides), increased low-density lipoprotein (LDL) oxidation and increased inflammation. All cluster members exacerbate T2DM. Methods. Sixteen patients with well-controlled T2DM participated in this double-blind randomized, placebo-controlled crossover study consisting of four visits. Apolipoprotein E genotyping was done at visit one. The cluster of seven, diet, exercise, smoking and medication use were assessed at each visit. Results. The 3/4 genotype showed a stronger downward trend in systolic blood pressure compared to the 3/3 genotype with no trend or significant difference in the 2/4 genotype. There was a downward trend in diastolic blood pressure in genotype 3/3 compared genotype 2/4, which showed no significant difference or trend. Only genotype 3/4 showed a significant drop in diastolic pressure compared to genotypes 2/4 and 3/3. HDLc only showed a downward trend in 3/4 relative to genotypes 2/4 and 3/3. LDL apolipoprotein B oxidation (LDL-Box) only showed an upward trend in 3/3 compared to genotypes 2/4 and 3/4. There were no other significant differences or trends by genotype in the cluster of seven. Conclusions. It appears that those with the 2/4 genotype may not benefit from FLC, those with 3/3 and 3/4 genotypes may benefit only in terms of systolic and diastolic pressures, those with the apo E 3/4 genotype should perhaps avoid FLC to manage HDLc, and those with the 3/3 genotype should perhaps avoid FLC to manage LDL apolipoprotein B oxidation.

研究目的该研究的目的是确定在服用亚麻籽木酚素复合物(FLC)的 2 型糖尿病(T2DM)老年人中,不同载脂蛋白 E 基因型的人对七项衡量指标中的一组指标的反应性是否存在统计学意义上的显著差异或趋势。这七项指标包括腹部肥胖、高血压、血小板过度聚集、高血糖、血脂异常(血浆中高密度脂蛋白胆固醇(HDLc)水平降低,血浆中甘油三酯水平升高)、低密度脂蛋白(LDL)氧化增加和炎症加剧。所有集群成员都会加重 T2DM。研究方法16 名病情控制良好的 T2DM 患者参加了这项双盲随机、安慰剂对照交叉研究,共进行了四次访视。在第一次就诊时进行载脂蛋白 E 基因分型。在每次就诊时评估七组患者的饮食、运动、吸烟和用药情况。结果显示与 3/3 基因型相比,3/4 基因型的收缩压呈更强的下降趋势,而 2/4 基因型则没有下降趋势或显著差异。与 2/4 基因型相比,3/3 基因型的舒张压呈下降趋势,但无显著差异或趋势。与基因型 2/4 和 3/3 相比,只有基因型 3/4 的舒张压有明显下降。与基因型 2/4 和 3/3 相比,只有基因型 3/4 的高密度脂蛋白胆固醇呈下降趋势。与基因型 2/4 和 3/4 相比,只有 3/3 中的低密度脂蛋白 B 氧化(LDL-Box)呈上升趋势。在七个基因型组中,没有其他明显的差异或趋势。结论。看来,2/4基因型的人可能不会从FLC中获益,3/3和3/4基因型的人可能仅在收缩压和舒张压方面获益,载脂蛋白E 3/4基因型的人或许应避免使用FLC来管理高密度脂蛋白胆固醇,而3/3基因型的人或许应避免使用FLC来管理低密度脂蛋白B氧化。
{"title":"Various apolipoprotein E genotypes relate to responsiveness to flaxseed lignan complex in older persons with type 2 diabetes mellitus.","authors":"Douglas E Barre, Kazimiera A Mizier-Barre, Odette Griscti","doi":"10.2478/enr-2024-0026","DOIUrl":"10.2478/enr-2024-0026","url":null,"abstract":"<p><p><b>Objective.</b> The objective of the study was to determine if there would be statistically significant differences or trends among apolipoprotein E genotypes in the responsiveness of members of a cluster of seven measures in older persons with type 2 diabetes mellitus (T2DM) consuming flaxseed lignan complex (FLC). The cluster of seven are abdominal obesity, hypertension, platelet hyperaggregability, hyperglycemia, dyslipidemia (decreased plasma levels of high-density lipoprotein cholesterol (HDLc), and increased plasma levels of triglycerides), increased low-density lipoprotein (LDL) oxidation and increased inflammation. All cluster members exacerbate T2DM. <b>Methods.</b> Sixteen patients with well-controlled T2DM participated in this double-blind randomized, placebo-controlled crossover study consisting of four visits. Apolipoprotein E genotyping was done at visit one. The cluster of seven, diet, exercise, smoking and medication use were assessed at each visit. <b>Results.</b> The 3/4 genotype showed a stronger downward trend in systolic blood pressure compared to the 3/3 genotype with no trend or significant difference in the 2/4 genotype. There was a downward trend in diastolic blood pressure in genotype 3/3 compared genotype 2/4, which showed no significant difference or trend. Only genotype 3/4 showed a significant drop in diastolic pressure compared to genotypes 2/4 and 3/3. HDLc only showed a downward trend in 3/4 relative to genotypes 2/4 and 3/3. LDL apolipoprotein B oxidation (LDL-Box) only showed an upward trend in 3/3 compared to genotypes 2/4 and 3/4. There were no other significant differences or trends by genotype in the cluster of seven. <b>Conclusions.</b> It appears that those with the 2/4 genotype may not benefit from FLC, those with 3/3 and 3/4 genotypes may benefit only in terms of systolic and diastolic pressures, those with the apo E 3/4 genotype should perhaps avoid FLC to manage HDLc, and those with the 3/3 genotype should perhaps avoid FLC to manage LDL apolipoprotein B oxidation.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"220-224"},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selenium - its role in physiology and endocrinology and as organoselenium compounds in oncology: A minireview. 硒--在生理学和内分泌学中的作用,以及作为有机硒化合物在肿瘤学中的作用:小视角。
Q3 Medicine Pub Date : 2024-11-21 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0028
Julius Brtko, Jan Podoba, Dana Macejova

The present minireview traces the road leading to discovery of selenium, formerly appointed as a toxic element that became later a bioelement, which is necessary for the proper functioning of living organisms. Selenium occurs in human and animal bodies either in the form of seleno-Lcysteine or its dimeric form seleno-L-cystine as a crucial component of selenoenzymes or selenoproteins. Selenium atom represents an integral component of the enzyme active site of different forms of glutathione peroxidase, which catalyzes conversion of hydrogen peroxide and organic hydroperoxides into the water and corresponding alcohols. A revolutionary breakthrough in the field of endocrinology came with the identification of different forms of iodothyronine deiodinase as selenoenzymes, which play an important role in the metabolism of thyroid hormone. The role of selenium in immune function and autoimmune thyropathies that might be associated with selenium deficiency are reported and discussed. This minireview also brings forward novel directions of organoselenium compounds or selenium nanoparticles in cancer therapy. Based on the update of available literature and the author's experimental experience, the minireview can be devoted to clinicians and medical students.

硒以前被认为是一种有毒元素,后来成为一种生物元素,是生物体正常运作所必需的。硒在人体和动物体内以硒-L-半胱氨酸或其二聚形式硒-L-胱氨酸的形式存在,是硒酶或硒蛋白的重要组成部分。硒原子是不同形式的谷胱甘肽过氧化物酶的酶活性位点的重要组成部分,谷胱甘肽过氧化物酶催化过氧化氢和有机氢过氧化物转化为水和相应的醇。内分泌学领域的一项革命性突破是确定了不同形式的碘甲腺原氨酸脱碘酶为硒酶,它们在甲状腺激素的新陈代谢中发挥着重要作用。报告还讨论了硒在免疫功能中的作用以及可能与缺硒有关的自身免疫性甲状腺疾病。本微综述还提出了有机硒化合物或硒纳米粒子在癌症治疗中的新方向。基于现有文献的更新和作者的实验经验,本微综述可供临床医生和医科学生参考。
{"title":"Selenium - its role in physiology and endocrinology and as organoselenium compounds in oncology: A minireview.","authors":"Julius Brtko, Jan Podoba, Dana Macejova","doi":"10.2478/enr-2024-0028","DOIUrl":"https://doi.org/10.2478/enr-2024-0028","url":null,"abstract":"<p><p>The present minireview traces the road leading to discovery of selenium, formerly appointed as a toxic element that became later a bioelement, which is necessary for the proper functioning of living organisms. Selenium occurs in human and animal bodies either in the form of seleno-Lcysteine or its dimeric form seleno-L-cystine as a crucial component of selenoenzymes or selenoproteins. Selenium atom represents an integral component of the enzyme active site of different forms of glutathione peroxidase, which catalyzes conversion of hydrogen peroxide and organic hydroperoxides into the water and corresponding alcohols. A revolutionary breakthrough in the field of endocrinology came with the identification of different forms of iodothyronine deiodinase as selenoenzymes, which play an important role in the metabolism of thyroid hormone. The role of selenium in immune function and autoimmune thyropathies that might be associated with selenium deficiency are reported and discussed. This minireview also brings forward novel directions of organoselenium compounds or selenium nanoparticles in cancer therapy. Based on the update of available literature and the author's experimental experience, the minireview can be devoted to clinicians and medical students.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"233-241"},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alpha-adducin 1 (rs4961) gene and its expression associated with sodium sensitivity in hypertensive patients: a cohort study in the western Ukrainian population. α-adducin1(rs4961)基因及其表达与高血压患者的钠敏感性相关:一项针对乌克兰西部人群的队列研究。
Q3 Medicine Pub Date : 2024-10-01 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0023
Larysa Sydorchuk, Bogdan Lytvyn, Andrii Sydorchuk, Yulia Yarynych, Sai Praveen Daruvuri, Svitlana Semenenko, Alisa Hoshovska, Ruslan Sydorchuk, Igor Biryuk

Objective. The aim of this study was to evaluate the association of the α-adducin-1 gene (ADD1) (Gly460Trp [rs4961]) polymorphism and its expression in association with renal dysfunction and sodium sensitivity in hypertensive patients in western Ukrainian population. Methods. One-hundred patients with essential arterial hypertension (EAH) and hypertensive-mediated target organ damage (stage 2), moderate, high, and very high cardiovascular risk were enrolled in case-control study. Sixty healthy individuals were assigned as controls. Sodium sensitivity and sodium resistance were determined by salt load reaction. The ADD1 (rs4961) genotyping was performed in RT-PCR. Results. The expression of the quantitative trait loci (eQTL) of ADD1 gene (rs4961) (chr4:2906707 [hg19]) was confirmed in 37 tissues and organs with 23 phenotypic traits. Two hundred eQTL associations revealed - all cis-variants (cis-QTL); 73 methylation QTL (mQTL), 34 splicing QTL (sQTL), 14 histone modification QTL (hQTL), 2 protein QTL (pQTL), 23 transcript utilization QTL (tuQTL), and 4 loci of incorporated long noncoding areas of RNA (lncRNA). GG-genotype unreliably enhances EAH risk (OR=1.92; 95%CI: 0.90-4.10; p=0.066). Sodium sensitivity was observed in 54.0% of patients and in 20.0% of controls (c2=17.89; p<0.001). Sodium sensitivity in T-allele carriers of the ADD1 gene (1378G>T; rs4961) dominated 12-fold in general (OR 95%CI: 2.24-64.29; p=0.001), in women - 4.71 times (OR 95%CI: 1.92-11.56; p<0.001), and in men - 4.09 times (OR 95%CI: 1.03-16.28; p=0.041). Sodium sensitivity elevated the likelihood of severe EAH twice (OR=2.19; OR 95%CI: 1.00-5.05; p=0.049). Conclusion. T-allele associates with sodium sensitivity in essential arterial hypertension patients and increases the risk of hypertension regardless the gender. Sodium sensitivity enhances the probability of severe essential arterial hypertension in observed population.

研究目的本研究旨在评估乌克兰西部人群中α-adducin-1基因(ADD1)(Gly460Trp [rs4961])多态性及其表达与高血压患者肾功能障碍和钠敏感性的相关性。研究方法100 名患有原发性动脉高血压(EAH)和高血压介导的靶器官损害(2 期)、中度、高度和极高度心血管风险的患者被纳入病例对照研究。60 名健康人作为对照组。通过盐负荷反应测定钠敏感性和钠抵抗性。通过 RT-PCR 对 ADD1 (rs4961) 进行基因分型。结果ADD1基因(rs4961)(chr4:2906707 [hg19])的数量性状位点(eQTL)在37个组织和器官中的表达与23个表型性状得到了证实。发现了 200 个 eQTL 关联--所有顺式变异(cis-QTL)、73 个甲基化 QTL(mQTL)、34 个剪接 QTL(sQTL)、14 个组蛋白修饰 QTL(hQTL)、2 个蛋白质 QTL(pQTL)、23 个转录本利用 QTL(tuQTL)和 4 个纳入 RNA 长非编码区(lncRNA)的位点。GG基因型不可靠地增加了EAH风险(OR=1.92;95%CI:0.90-4.10;p=0.066)。54.0%的患者和20.0%的对照组(c2=17.89;pADD1基因(1378G>T;rs4961)对钠的敏感性占主导地位,一般为12倍(OR 95%CI:2.24-64.29;p=0.001),女性为4.71倍(OR 95%CI:1.92-11.56;p结论。T-等位基因与原发性动脉高血压患者的钠敏感性有关,并增加了高血压的风险,与性别无关。在观察人群中,钠敏感性会增加患严重本质性动脉高血压的概率。
{"title":"Alpha-adducin 1 (rs4961) gene and its expression associated with sodium sensitivity in hypertensive patients: a cohort study in the western Ukrainian population.","authors":"Larysa Sydorchuk, Bogdan Lytvyn, Andrii Sydorchuk, Yulia Yarynych, Sai Praveen Daruvuri, Svitlana Semenenko, Alisa Hoshovska, Ruslan Sydorchuk, Igor Biryuk","doi":"10.2478/enr-2024-0023","DOIUrl":"10.2478/enr-2024-0023","url":null,"abstract":"<p><p><b>Objective.</b> The aim of this study was to evaluate the association of the α-adducin-1 gene (<i>ADD1</i>) (Gly460Trp [rs4961]) polymorphism and its expression in association with renal dysfunction and sodium sensitivity in hypertensive patients in western Ukrainian population. <b>Methods.</b> One-hundred patients with essential arterial hypertension (EAH) and hypertensive-mediated target organ damage (stage 2), moderate, high, and very high cardiovascular risk were enrolled in case-control study. Sixty healthy individuals were assigned as controls. Sodium sensitivity and sodium resistance were determined by salt load reaction. The <i>ADD1</i> (rs4961) genotyping was performed in RT-PCR. <b>Results.</b> The expression of the quantitative trait loci (eQTL) of <i>ADD1</i> gene (rs4961) (chr4:2906707 [hg19]) was confirmed in 37 tissues and organs with 23 phenotypic traits. Two hundred eQTL associations revealed - all cis-variants (cis-QTL); 73 methylation QTL (mQTL), 34 splicing QTL (sQTL), 14 histone modification QTL (hQTL), 2 protein QTL (pQTL), 23 transcript utilization QTL (tuQTL), and 4 loci of incorporated long noncoding areas of RNA (lncRNA). GG-genotype unreliably enhances EAH risk (OR=1.92; 95%CI: 0.90-4.10; p=0.066). Sodium sensitivity was observed in 54.0% of patients and in 20.0% of controls (c2=17.89; p<0.001). Sodium sensitivity in T-allele carriers of the <i>ADD1</i> gene (1378G>T; rs4961) dominated 12-fold in general (OR 95%CI: 2.24-64.29; p=0.001), in women - 4.71 times (OR 95%CI: 1.92-11.56; p<0.001), and in men - 4.09 times (OR 95%CI: 1.03-16.28; p=0.041). Sodium sensitivity elevated the likelihood of severe EAH twice (OR=2.19; OR 95%CI: 1.00-5.05; p=0.049). <b>Conclusion.</b> T-allele associates with sodium sensitivity in essential arterial hypertension patients and increases the risk of hypertension regardless the gender. Sodium sensitivity enhances the probability of severe essential arterial hypertension in observed population.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"195-205"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoplasmic reticulum stress-dependent regulation of carboxypeptidase E expression in glioblastoma cells. 内质网应激对胶质母细胞瘤细胞中羧肽酶 E 表达的依赖性调控
Q3 Medicine Pub Date : 2024-10-01 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0024
Oleksandr H Minchenko, Anastasiia I Abramchuk, Olena O Khita, Myroslava Y Sliusar, Yuliia M Viletska, Dmytro O Minchenko

Objective. Carboxypeptidase E (CPE) plays an important role in the biosynthesis of neurotransmitters and peptide hormones including insulin. It also promotes cell proliferation, survival, and invasion of tumor cells. The endoplasmic reticulum stress, hypoxia, and nutrient supply are significant factors of malignant tumor growth including glioblastoma. There are data indicating that the knockdown of the endoplasmic reticulum to nucleus signaling 1 (ERN1) suppressed glioblastoma cell proliferation and increased invasiveness of these cells. The present study aims to investigate the regulation of the CPE gene in U87MG glioblastoma cells by ERN1 knockdown, hypoxia, and glucose or glutamine deprivations with the intent to reveal the role of ERN1 signaling in the regulation of this gene expression and function in tumorigenesis. Methods. Human glioblastoma cells U87MG (transfected by an empty vector; control) and ERN1 knockdown cells with inhibited ERN1 endoribonuclease and protein kinase (dnERN1) or only ERN1 endoribonuclease (dnrERN1) were used. Hypoxia was introduced by dimethyloxalylglycine; for glucose and glutamine deprivations, the cells were cultured in DMEM medium without glucose or glutamine for 16 h, respectively. The expression level of the CPE gene was studied by quantitative RT-PCR and normalized to ACTB. Results. It was found that inhibition of endoribonuclease and protein kinase activities of ERN1 led to a strong up-regulation of CPE gene expression in glioblastoma cells. The expression of this gene also increased in glioblastoma cells after silencing ERN1. At the same time, the expression of this gene did not significantly change in cells with inhibited ERN1 endoribonuclease only. The expression of the CPE gene was resistant to hypoxia in control U87MG cells, but increased in cells with ERN1 knockdown. The expression of this gene was up-regulated under glutamine deprivation in control glioblastoma cells, but decreased upon ERN1 knockdown. However, glucose deprivation decreased the expression of CPE gene in both types of used cells, but ERN1 inhibition enhanced this effect. Conclusion. The results of the present study demonstrate that inhibition of ERN1 strongly up-regulated the expression of pro-oncogenic CPE gene through protein kinase activity of ERN1 and that increased CPE gene expression possibly participates in ERN1 knockdown-mediated invasiveness of glioblastoma cells.

目的:羧肽酶 E(CPE羧肽酶 E(CPE)在神经递质和肽类激素(包括胰岛素)的生物合成过程中发挥着重要作用。它还能促进细胞增殖、存活和肿瘤细胞的侵袭。内质网应激、缺氧和营养供应是包括胶质母细胞瘤在内的恶性肿瘤生长的重要因素。有数据表明,敲除内质网到细胞核信号转导1(ERN1)可抑制胶质母细胞瘤细胞的增殖,并增加这些细胞的侵袭性。本研究旨在探讨ERN1敲除、缺氧、葡萄糖或谷氨酰胺剥夺对U87MG胶质母细胞瘤细胞中CPE基因的调控,以期揭示ERN1信号传导在调控该基因表达及肿瘤发生过程中的作用。研究方法使用人胶质母细胞瘤细胞 U87MG(用空载体转染;对照组)和ERN1内切核酸酶和蛋白激酶抑制型(dnERN1)或仅ERN1内切核酸酶抑制型(dnrERN1)的ERN1基因敲除细胞。缺氧由二甲基氧丙基甘氨酸引起;葡萄糖和谷氨酰胺剥夺时,细胞分别在不含葡萄糖或谷氨酰胺的 DMEM 培养基中培养 16 小时。CPE 基因的表达水平通过定量 RT-PCR 进行研究,并与 ACTB 进行归一化。结果显示研究发现,抑制 ERN1 的内切酶和蛋白激酶活性会导致 CPE 基因在胶质母细胞瘤细胞中的表达强烈上调。沉默ERN1后,该基因在胶质母细胞瘤细胞中的表达也有所增加。同时,在仅抑制 ERN1 内切酶的细胞中,该基因的表达没有明显变化。在对照组的 U87MG 细胞中,CPE 基因的表达对缺氧有抵抗作用,但在敲除 ERN1 的细胞中,CPE 基因的表达增加。对照组胶质母细胞瘤细胞在谷氨酰胺匮乏条件下,该基因的表达上调,但在ERN1基因敲除后则下降。然而,葡萄糖剥夺会降低两种所用细胞中 CPE 基因的表达,但 ERN1 抑制会增强这种效应。结论本研究结果表明,抑制ERN1可通过ERN1的蛋白激酶活性强烈上调促癌CPE基因的表达,而CPE基因表达的增加可能参与了ERN1敲除介导的胶质母细胞瘤细胞侵袭性。
{"title":"Endoplasmic reticulum stress-dependent regulation of carboxypeptidase E expression in glioblastoma cells.","authors":"Oleksandr H Minchenko, Anastasiia I Abramchuk, Olena O Khita, Myroslava Y Sliusar, Yuliia M Viletska, Dmytro O Minchenko","doi":"10.2478/enr-2024-0024","DOIUrl":"10.2478/enr-2024-0024","url":null,"abstract":"<p><p><b>Objective.</b> Carboxypeptidase E (CPE) plays an important role in the biosynthesis of neurotransmitters and peptide hormones including insulin. It also promotes cell proliferation, survival, and invasion of tumor cells. The endoplasmic reticulum stress, hypoxia, and nutrient supply are significant factors of malignant tumor growth including glioblastoma. There are data indicating that the knockdown of the endoplasmic reticulum to nucleus signaling 1 (ERN1) suppressed glioblastoma cell proliferation and increased invasiveness of these cells. The present study aims to investigate the regulation of the <i>CPE</i> gene in U87MG glioblastoma cells by ERN1 knockdown, hypoxia, and glucose or glutamine deprivations with the intent to reveal the role of ERN1 signaling in the regulation of this gene expression and function in tumorigenesis. <b>Methods.</b> Human glioblastoma cells U87MG (transfected by an empty vector; control) and ERN1 knockdown cells with inhibited ERN1 endoribonuclease and protein kinase (dnERN1) or only ERN1 endoribonuclease (dnrERN1) were used. Hypoxia was introduced by dimethyloxalylglycine; for glucose and glutamine deprivations, the cells were cultured in DMEM medium without glucose or glutamine for 16 h, respectively. The expression level of the <i>CPE</i> gene was studied by quantitative RT-PCR and normalized to ACTB. <b>Results.</b> It was found that inhibition of endoribonuclease and protein kinase activities of ERN1 led to a strong up-regulation of <i>CPE</i> gene expression in glioblastoma cells. The expression of this gene also increased in glioblastoma cells after silencing ERN1. At the same time, the expression of this gene did not significantly change in cells with inhibited ERN1 endoribonuclease only. The expression of the <i>CPE</i> gene was resistant to hypoxia in control U87MG cells, but increased in cells with ERN1 knockdown. The expression of this gene was up-regulated under glutamine deprivation in control glioblastoma cells, but decreased upon ERN1 knockdown. However, glucose deprivation decreased the expression of <i>CPE</i> gene in both types of used cells, but ERN1 inhibition enhanced this effect. <b>Conclusion.</b> The results of the present study demonstrate that inhibition of ERN1 strongly up-regulated the expression of pro-oncogenic <i>CPE</i> gene through protein kinase activity of ERN1 and that increased <i>CPE</i> gene expression possibly participates in ERN1 knockdown-mediated invasiveness of glioblastoma cells.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"206-214"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical evaluation of CoolSeal - a new, safe, and fast vessel sealing device in total thyroidectomy. CoolSeal--一种新型、安全、快速的血管密封装置在甲状腺全切除术中的临床评估。
Q3 Medicine Pub Date : 2024-10-01 Print Date: 2024-01-01 DOI: 10.2478/enr-2024-0021
Mette Vold Hansen, Rasmus Reinke, Stefano Christian Londero, Lars Rolighed

Objective. CoolSeal is a new vessel sealing system for dissection and hemostasis during surgery. No clinical studies have investigated safety, advantages or disadvantages regarding the use of this device. The aim of the present study was to investigate the safety of CoolSeal and compare it with conventional ligation technique or LigaSure during the total thyroidectomy. We hypothesized that the use of CoolSeal would reduce the operating time and bleeding without complications increase. Study design represents a retrospective cohort study with a tertiary reference center setting. Methods. We analyzed total thyroidectomy data from January 2021 to June 2023. We recorded patients' characteristics, surgical information, and postoperative outcome. Results. We performed 221 total thyroidectomies in the study period. Analysis was restricted to 171 patients operated by only two surgeons. Hemostasis was secured by conventional ligation in 117 patients (68%), LigaSure in 34 patients (20%) and CoolSeal in 20 patients (12%). Median thyroid weight and bleeding were 67 g and 50 ml, respectively. Procedures using LigaSure or Cool-Seal were on larger glands (median 205 g) without increased bleeding (50 ml). Operating time was shortest with CoolSeal (96 min, p=0.003) compared with LigaSure (117 min) or conventional ligation (115 min). Bleeding was reduced with CoolSeal compared with LigaSure (45 vs. 100 ml, p=0.003). With CoolSeal, median hospitalization was one postoperative day, no patients required re-operation. There was no palsy of recurrent laryngeal nerves and no permanent hypoparathyroidism. Conclusion. In our first clinical experience, CoolSeal was safe and efficient for total thyroidectomy. With a small sample size, we saw a clinical benefit with reduced operating time without post-operative complications increase.

目的。CoolSeal 是一种新型血管密封系统,用于手术中的剥离和止血。目前还没有临床研究对使用该设备的安全性、优缺点进行调查。本研究旨在调查 CoolSeal 的安全性,并将其与甲状腺全切除术中的传统结扎技术或 LigaSure 进行比较。我们假设使用 CoolSeal 可以减少手术时间和出血量,而不会增加并发症。研究设计是一项在三级参考中心环境下进行的回顾性队列研究。研究方法我们分析了 2021 年 1 月至 2023 年 6 月的甲状腺全切除术数据。我们记录了患者的特征、手术信息和术后结果。结果在研究期间,我们共进行了 221 例甲状腺全切除术。分析对象仅限于仅由两名外科医生进行手术的 171 例患者。117例患者(68%)采用常规结扎止血,34例患者(20%)采用LigaSure止血,20例患者(12%)采用CoolSeal止血。甲状腺重量和出血量的中位数分别为 67 克和 50 毫升。使用 LigaSure 或 Cool-Seal 手术的腺体较大(中位 205 克),但出血量(50 毫升)没有增加。与 LigaSure(117 分钟)或传统结扎(115 分钟)相比,CoolSeal 的手术时间最短(96 分钟,P=0.003)。与 LigaSure 相比,CoolSeal 的出血量更少(45 毫升对 100 毫升,P=0.003)。使用 CoolSeal,中位住院时间为术后一天,没有患者需要再次手术。没有发生喉返神经麻痹和永久性甲状旁腺功能减退。结论在我们的首次临床实践中,CoolSeal 用于甲状腺全切术是安全有效的。在样本量较小的情况下,我们看到了手术时间缩短而术后并发症不增加的临床益处。
{"title":"Clinical evaluation of CoolSeal - a new, safe, and fast vessel sealing device in total thyroidectomy.","authors":"Mette Vold Hansen, Rasmus Reinke, Stefano Christian Londero, Lars Rolighed","doi":"10.2478/enr-2024-0021","DOIUrl":"10.2478/enr-2024-0021","url":null,"abstract":"<p><p><b>Objective.</b> CoolSeal is a new vessel sealing system for dissection and hemostasis during surgery. No clinical studies have investigated safety, advantages or disadvantages regarding the use of this device. The aim of the present study was to investigate the safety of CoolSeal and compare it with conventional ligation technique or LigaSure during the total thyroidectomy. We hypothesized that the use of CoolSeal would reduce the operating time and bleeding without complications increase. Study design represents a retrospective cohort study with a tertiary reference center setting. <b>Methods.</b> We analyzed total thyroidectomy data from January 2021 to June 2023. We recorded patients' characteristics, surgical information, and postoperative outcome. <b>Results.</b> We performed 221 total thyroidectomies in the study period. Analysis was restricted to 171 patients operated by only two surgeons. Hemostasis was secured by conventional ligation in 117 patients (68%), LigaSure in 34 patients (20%) and CoolSeal in 20 patients (12%). Median thyroid weight and bleeding were 67 g and 50 ml, respectively. Procedures using LigaSure or Cool-Seal were on larger glands (median 205 g) without increased bleeding (50 ml). Operating time was shortest with CoolSeal (96 min, p=0.003) compared with LigaSure (117 min) or conventional ligation (115 min). Bleeding was reduced with CoolSeal compared with LigaSure (45 vs. 100 ml, p=0.003). With CoolSeal, median hospitalization was one postoperative day, no patients required re-operation. There was no palsy of recurrent laryngeal nerves and no permanent hypoparathyroidism. <b>Conclusion.</b> In our first clinical experience, CoolSeal was safe and efficient for total thyroidectomy. With a small sample size, we saw a clinical benefit with reduced operating time without post-operative complications increase.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"181-186"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrine regulations
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1